Our CEO’s perspective on 2 key topics that will impact payer strategy in 2023.

PM360 asked experts in developing market access strategies how the Inflation Reduction Act will impact drug pricing negotiation and other access-related issues as well as what other big trends in the space will force the industry to rethink its strategies. 

See how our own Dan Renick responded: